HGWM
AMPH icon

Harvest Group Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Harvest Group Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12
Closed – – 68
2020
Q4 		$0 Hold
12
– – ﹤0.01% 639
2020
Q3 		$0 Hold
12
– – ﹤0.01% 581
2020
Q2 		$0 Hold
12
– – ﹤0.01% 478
2020
Q1 		$0 Buy
+12
New +$209 ﹤0.01% 496

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Harvest Group Wealth Management's AMPH Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2021, closing a stake of 12 shares.

Harvest Group Wealth Management first reported a position in AMPH in Q1 2020 and held it in 4 quarters. The position peaked at $0 in Q4 2020. 135 funds tracked by Wall St. Rank hold AMPH as of Q1 2021.

  • Harvest Group Wealth Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Harvest Group Wealth Management sold 12 Amphastar Pharmaceuticals shares in Q1 2021.
  • Harvest Group Wealth Management first reported a position in Amphastar Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Harvest Group Wealth Management's Amphastar Pharmaceuticals position peaked at $0 in Q4 2020.
  • 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.